One step closer to NASDAQ, page-7

Will there be a joint company CELS=AVH+RenovaCare
"...

Dr. Frank Gerberick, Procter & Gamble Product Safety Veteran, Joins RenovaCare Scottsdale, AZ – September 24, 2019- RenovaCare, Inc. (Symbol: RCAR;www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, is pleased to announce the appointment of Dr. Frank Gerberick to its Board of Advisors to help advance the Company’s SkinGun™ cell spray technology for the regeneration of human skin. “My career has been focused around product safety – specifically around contact dermatitis. The proven rapid-healing and therapeutic benefits of the RenovaCare SkinGun™ and CellMist™ solution through use of a person’s own stem cells is an exciting, cutting-edge technology to study. One of the key areas of bringing a medical device to market is mitigating adverse events such as the occurrence of skin allergy. I look forward to working with the RenovaCare team and sharing with them my expertise in these areas in order to bring this much needed therapy to market,” stated Dr. Frank Gerberick, RenovaCare Advisory Board Member. Today’s news follows last month’s appointment of RenovaCare Vice-President of Scientific Affairs, Dr. Robin Robinson, founding director of BARDA and cited in 2018 as one of the top 100 innovators in medicine by The Medicine Maker. Just prior, the USPTO awarded a new patent to RenovaCare, allowing its SkinGun™ to spray all varieties of tissues and cells, and thus opening the door for its potential application in regenerative applications beyond skin. Recent breakthroughs in stem cell therapies include the regeneration of human organs, tissues and bone. RenovaCare believes that the ultra-gentle spray-on application of such cells could be investigated and developed by way of commercial collaborations and partnerships. (from RenovaCare Press release)